LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19
A Promising Response to the Global Unprecedented Pandemic
- 1st Edition - November 1, 2024
- Editors: Nabeelah Bibi Sadeer, Thomas Efferth
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 7 5 7 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 7 5 8 - 2
Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19: A Promising Response to the Global Unprecedented Pandemic presents comprehen… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteTraditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19: A Promising Response to the Global Unprecedented Pandemic presents comprehensive coverage of the pharmacological effects of natural products on the prevention and treatment of COVID-19. Sections provide traditional medicine approaches and their potential to prevent and treat COVID-19 infection, including traditional Chinese, Ayurvedic, Persian, and Kampo medicine, alongside an overview of nutritional regimens and their therapeutic potential. Other sections cover natural molecules such as flavonoids, saponins, coumarins, alkaloids, terpenes, polysaccharides, and several microbial natural products of relevant action against viruses. Final chapters cover nanotherapeutic approaches.
This is a valuable resource for researchers and academics in the fields of herbal medicine, pharmacology, pharmacognosy and for professionals in the pharmaceutical industries and anyone interested in natural products and their application for therapeutic purposes.
- Provides a complete overview of how natural products can be used to prevent and combat the COVID-19 virus and its associated complications
- Discusses the full extent of what is known to date and provides a thorough view on how herbal medicine can tackle illnesses caused by the COVID-19 pandemic
- Presents insights that healthcare and herbal medicine professionals need to prevent, diagnose and treat COVID-19
Graduate students in pharmacology and Pharmacognosy, Respiratory therapists, Virologists, Pathologists
PART I: Traditional herbal medicines
1. Traditional medicines and natural products for COVID-19: Potential and limitations
2. Recent advances of Traditional Chinese medicine against COVID-19 pandemic
3. The efficacy of Ayurvedic medicine in the prevention and treatment of COVID-19
4. Traditional Persian medicine as a holistic therapeutic approach in managing COVID-19
5. The potential application of Kampo medicine against SARS-CoV-2
6. Functional food components for the management and prevention of COVID-19 and its associated
7. The potential of ketogenic dietary therapy in COVID-19 pandemic
PART II: Natural products and Natural product-based new medicinal products
8. Flavonoids as potential inhibitors targeting SARS-CoV-2
9. Saponins as potential inhibitors targeting SARS-CoV-2
10. Coumarins as potential inhibitors targeting SARS-CoV-2
11. Alkaloids as potential inhibitors targeting SARS-CoV-2
12. Terpenes and terpenoids as potential inhibitors targeting SARS-CoV-2
13. Polysaccharides as potential inhibitors targeting SARS-CoV-2
14. Evaluating microbial natural products as potential SARS-CoV-2 inhibitors
15. Towards natural polymers and nanoparticles as nano-therapies to combat COVID-19
16. Natural products from mushrooms as versatile therapeutic and preventive inhibitors to COVID-19
- No. of pages: 400
- Language: English
- Edition: 1
- Published: November 1, 2024
- Imprint: Academic Press
- Paperback ISBN: 9780443187575
NS
Nabeelah Bibi Sadeer
Nabeelah received her M.S. degree in Forensic Science at Staffordshire University (U.K.) in 2016 and her B.S. degree in Chemistry at University of Mauritius (Mauritius) in 2014. Since 2017, she has been pursuing her Ph.D. at the Department of Health Sciences at the University of Mauritius under the supervision of Prof. (Dr.) Fawzi Mahomoodally. Her current research focuses on the phytochemical analysis and pharmacological properties of mangrove plants and their associated fungal endophytes. She is an Associate Member of the Royal Society of Chemistry. Nabeelah is efficient at multitasking, can effectively lead a team and works well either independently or in group. In her short period as PhD student (since 2017), Nabeelah has authored and co-authored 30 publications in high impact factor journals and prestigious books with several other articles and book chapters under preparation/review.
Affiliations and expertise
Pursuing her Ph.D., Department of Health Sciences, University of Mauritius, MauritiusTE
Thomas Efferth
Thomas Efferth is chair of the Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany. He is biologist by training (Technical University of Darmstadt, Germany). His doctoral thesis was completed at the German Cancer Research Center (DKFZ), Heidelberg, Germany (1990). Dr. Efferth was awarded the Ludolf-Krehl-Prize of the Southwest German Association for Medicine (1991), the Willmar-Schwabe-Award of the German Society for Medicinal Plant Research (2006), the citizen medal of the City of Heidelberg, Germany (2008), the CESAR Award for Translational Oncology (2011), and the SCENTEDdrop Award on medicinal and flagrant herbs (2015). He headed a research group for Pharmaceutical Biology at DKFZ (2005-2009) and was associate professor (apl) at the University of Heidelberg (2007-2009). In 2009, he took over the Chair of Pharmaceutical Biology (full professorship) at the Johannes Gutenberg University, Mainz. Furthermore, he is honorary professor at the Northeast Forestry University, Harbin, and at the Zhejiang Chinese Medical University, Hangzhou, China. Moreover, he is visiting professor at the Zhejiang University of Science and Technology, Hangzhou, China.
He is editor-in-chief, co-editor, associate editor and editorial board member of 30 scientific journals and scientific advisory board member of the German Pharmaceutical Society and several other institutions. Seven of his former lab members promoted to associate or assistant professors.
The focus of Dr. Efferth's research is on tumor pharmacology, pharmacogenomics, and the development of novel options for treatment and diagnosis of cancer. A major topic is research on chemical entities from natural sources.
Affiliations and expertise
Chair of Department, Institute of Pharmaceutical and Biomedical Sciences, Department of Pharmaceutical Biology, Johannes Gutenberg University, Mainz, Germany